Neal Flomenberg
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Thomas Jefferson University · Thomas Jefferson University, Department of Medical Oncology
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
13
all conditions, ClinicalTrials.gov
NIH grants tied to them
3
3 more share only the name and are not shown
Trial papers
25
PubMed author-name match
Trials
Studies that name Neal Flomenberg as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 18:44 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03944265 · Genetics and Shared Decision Making in Improving Care for Patients With Stage IVA-C Non-small Cell Lung CancerThomas Jefferson University · completed · Activating ALK Gene Mutation Negative, Activating EGFR Gene Mutation Negative, Activating ROS1 Gene Mutation Negative · principal investigator
- Ph2NCT01760655 · Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic MalignanciesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM · principal investigator
- Ph2NCT01532635 · A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched RelativesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · terminated · Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia · principal investigator
- Ph1/Ph2NCT01350258 · Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two StepsSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · terminated · Hematologic Malignancies, Acute Leukemia, Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes · principal investigator
- Ph2NCT01350245 · Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative DonorSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Acute Myeloid Leukemia, Myelodysplastic Syndromes, Biphenotypic Leukemia · principal investigator
- Ph2NCT01341301 · Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic MalignanciesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Hematologic Malignancy · principal investigator
- Ph2NCT01315132 · A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological MalignanciesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Hematological Malignancies, Leukemia, Lymphoma · principal investigator
- Ph1/Ph2NCT01162096 · Reduced Intensity Haploidentical Transplant for Hematological MalignanciesSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Hematological Malignancies · principal investigator
- Ph2NCT00429039 · A Study to Accelerate Immune System Recovery Following Stem Cell TransplantationSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · terminated · ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION · principal investigator
- Ph1/Ph2NCT00429143 · A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched RelativeSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Hematologic Malignancies · principal investigator
- Ph2NCT00014508 · Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaEastern Cooperative Oncology Group · completed · Multiple Myeloma and Plasma Cell Neoplasm · study chair
- Ph1NCT00003268 · Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · completed · Drug/Agent Toxicity by Tissue/Organ, Leukemia · study chair
- Ph2NCT00003153 · Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow TransplantationEastern Cooperative Oncology Group · completed · Multiple Myeloma and Plasma Cell Neoplasm · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-11 18:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Matched and Haploidentical transplantation for Adults with Sickle Cell AnemiaRC2HL101496 · NHLBI · THOMAS JEFFERSON UNIVERSITY · fiscal years 2009 to 2010 · $960,323 awarded in 2010Same name and institution; not confirmed by an ID
- LLME TREATED T LYMPHOCYTE THERAPY AFTER ALLOGENEIC BMTR21CA091552 · NCI · THOMAS JEFFERSON UNIVERSITY · fiscal years 2001 to 2002 · $353,250 awarded in 2002Same name and institution; not confirmed by an ID
- EFFICACY AND TOXICITY OF CD4 PEPTIDE 802-2 IN HUMAN UNRELATED DONOR BONE MARROWP01CA077401 · NCI · THOMAS JEFFERSON UNIVERSITY · fiscal years 1999 to 2001 · $196,218 awarded in 2001Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 18:44 UTC. The ranking covers the 200 most relevant of 25 PubMed records, and a shared surname and initials can bring in a namesake. All 25 on PubMed
- 356 citationsRCR 7.3
- Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.J Clin Oncol · 2004330 citationsRCR 6.0
- Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes.Transplantation · 1987256 citationsRCR 6.4
- Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)Ann Intern Med · 1990207 citationsRCR 6.8
- Phase III randomized, double-blind placebo-controlled trial of rhGM-CSF following allogeneic bone marrow transplantation.Bone Marrow Transplant · 1995116 citationsRCR 3.7
- 67 citationsRCR 1.8
- 59 citationsRCR 1.8
- Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I study.Biol Blood Marrow Transplant · 200453 citationsRCR 1.3
- Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.Biol Blood Marrow Transplant · 200548 citationsRCR 1.2
- Heterogeneous clearance of antithymocyte globulin after CD34+-selected allogeneic hematopoietic progenitor cell transplantation.Biol Blood Marrow Transplant · 200538 citationsRCR 0.9